Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DALS

DA32 Life Science Tech Acquisition (DALS) Stock Price, News & Analysis

DA32 Life Science Tech Acquisition logo

About DA32 Life Science Tech Acquisition Stock (NASDAQ:DALS)

Key Stats

Today's Range
$10.30
$10.32
50-Day Range
$10.25
$10.32
52-Week Range
$9.68
$11.22
Volume
2,248 shs
Average Volume
88,802 shs
Market Capitalization
$264.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DALS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DA32 Life Science Tech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DALS Stock News Headlines

RLST:CA RBC Funds - RBC Life Science and Technology Fund
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel
T. Rowe Price Science & Tech
Global Technology Acquisition Corp I (GTAC)
DA32 Life Science Tech Acquisition Corp.
See More Headlines

DALS Stock Analysis - Frequently Asked Questions

DA32 Life Science Tech Acquisition (DALS) raised $200 million in an initial public offering (IPO) on Wednesday, July 28th 2021. The company issued 20,000,000 shares at a price of $10.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that DA32 Life Science Tech Acquisition investors own include Bridge Investment Group (BRDG), Blend Labs (BLND), Blue Foundry Bancorp (BLFY), Couchbase (BASE), ARYA Sciences Acquisition Corp V (ARYE), Argo Blockchain (ARBK) and a.k.a. Brands (AKA).

Company Calendar

Today
9/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:DALS
CIK
1863294
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$600 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-37.55%
Return on Assets
0.85%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.36
Quick Ratio
0.36

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.02 per share
Price / Cash Flow
441.92
Book Value
($0.18) per share
Price / Book
-57.33

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
$264.71 million
Optionable
Not Optionable
Beta
N/A
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:DALS) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners